(1)

According to Article 78(3) of Regulation (EC) No 1107/2009, active substances included in Annex I to Council Directive 91/414/EEC (2) are deemed to have been approved under Regulation (EC) No 1107/2009 and are listed in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (3). Active substances approved under Regulation (EC) No 1107/2009 are listed in Part B of the Annex to Implementing Regulation (EU) No 540/2011, and active substances approved under Regulation (EC) No 1107/2009 as candidates for substitution are listed in Part E of that Annex.

(2)

The active substances bensulfuron, chlormequat, chlorotoluron, clomazone, daminozide, deltamethrin, fludioxonil, flufenacet, fosthiazate, MCPA, MCPB, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulfuryl fluoride, tebufenpyrad and tritosulfuron are listed in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The active substances eugenol, geraniol and thymol are listed in Part B and the active substance flumetralin in Part E of that Annex.

(3)

Commission Implementing Regulation (EU) 2022/1480 (4) extended the approval period of the active substances bensulfuron, chlorotoluron, clomazone, daminozide, deltamethrin, fludioxonil, flufenacet, fosthiazate, MCPA, MCPB, prosulfocarb, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, and tebufenpyrad until 31 October 2023, of the active substances chlormequat, propaquizafop, quizalofop-P-ethyl, quizalofop-P-tefuryl and tritosulfuron until 30 November 2023 and of the active substance flumetralin until 11 December 2023.

(4)

Commission Implementing Regulation (EU) 2018/184 (5) extended the approval period of the active substance sulfuryl fluoride until 31 October 2023.

(5)

The approval of the active substance eugenol is set to expire on 30 November 2023 in accordance with Commission Implementing Regulation (EU) No 546/2013 (6).

(6)

The approval of the active substance geraniol is set to expire on 30 November 2023 in accordance with Commission Implementing Regulation (EU) No 570/2013 (7).

(7)

The approval of the active substance thymol is set to expire on 30 November 2023 in accordance with Commission Implementing Regulation (EU) No 568/2013 (8).

(8)

Applications and supplementary dossiers for the renewal of the approval of each of those active substances were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012 (9). All of these applications were declared admissible by the respective rapporteur Member States.

(9)

For the active substances chlormequat, eugenol, flumetralin, fosthiazate, geraniol, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulfuryl fluoride, tebufenpyrad and thymol, the risk assessment pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 has not yet been finalised by the respective rapporteur Member States.

(10)

For the active substances bensulfuron, chlorotoluron, deltamethrin, MCPA and MCPB, the European Food Safety Authority (‘the Authority’) needs additional time to reach a conclusion requiring, where appropriate, a consultation of experts. Furthermore, additional time is needed for the Commission to adopt the ensuing risk management decision.

(11)

For the active substances clomazone, daminozide, fludioxonil, flufenacet and tritosulfuron, additional information for the purposes of assessment of the approval criteria set out in point 3.6.5 and point 3.8.2 of Annex II to Regulation (EC) No 1107/2009, was requested by the Authority pursuant to Article 13(3a), first subparagraph, of Implementing Regulation (EU) No 844/2012 and was submitted by the applicants within the period set by the Authority. However, additional time is needed for the Authority to evaluate the information received and adopt a conclusion on whether the active substances can be expected to meet the approval criteria and for the Commission to adopt the ensuing risk management decision.

(12)

Given that it is likely that no decision on the renewal of the approval of these active substances can be taken before the expiry of their respective approval periods on 31 October 2023, 30 November 2023 and 11 December 2023, and that the reasons for the delays in the renewal procedures are beyond the control of the respective applicants, the approval periods of the active substances should be extended in order to enable the completion of the assessments required and finalise the regulatory decision-making procedures on the respective applications for renewal of approval.

(13)

As the risk assessment has not yet been finalised by the rapporteur Member States, and in light of the time required to complete the remaining steps in each renewal procedure, the duration of the extension for the active substances chlormequat, fosthiazate, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulfuryl fluoride and tebufenpyrad should be set at thirty-nine months and for the active substances eugenol, flumetralin, geraniol and thymol should be set at twenty-nine months.

(14)

As the Authority needs additional time to reach a conclusion on the risk assessment for the active substances bensulfuron, chlorotoluron, deltamethrin, MCPA and MCPB requiring, where appropriate, a consultation of experts, the duration of the extension for those active substances should be set at thirty-three months and a half.

(15)

As the Authority requested additional information for the purposes of assessment of the approval criteria set out in point 3.6.5 and point 3.8.2 of Annex II to Regulation (EC) No 1107/2009, the duration of the extension for the active substance daminozide should be set at twenty-two months and a half and, as additional time is needed for its evaluation, the duration of the extension for the active substances clomazone, fludioxonil, flufenacet and tritosulfuron should be set at nineteen months and a half.

(16)

Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

(17)

In case the Commission adopts a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed, the Commission will set the expiry date at the same date as it stood before the adoption of this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later. As regards cases where the Commission is to adopt a Regulation providing for the renewal of the approval of an active substance referred to in the Annex to this Regulation, the Commission will set, as appropriate under the circumstances, the earliest possible application date.

(18)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,